Salasani, Mohabil P.
HRN: 15-75-90 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/09/2023
12/16/2023
IV
375
Q6h
Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes